相似文献
1
Secondary effects of antipsychotics: women at greater risk than men.
Schizophr Bull. 2009 Sep;35(5):937-48. doi: 10.1093/schbul/sbn023. Epub 2008 Apr 9.
2
[Metabolic side effects of risperidone in early onset schizophrenia].
Encephale. 2010 Jun;36(3):242-52. doi: 10.1016/j.encep.2009.10.008. Epub 2009 Dec 1.
3
Atypical antipsychotics in the treatment of schizophrenia during pregnancy and the postpartum.
Am J Psychiatry. 2006 Dec;163(12):2064-70. doi: 10.1176/ajp.2006.163.12.2064.
4
Use and safety of antipsychotic drugs during pregnancy.
J Psychiatr Pract. 2009 May;15(3):183-92. doi: 10.1097/01.pra.0000351878.45260.94.
5
Schizophrenia, antipsychotics and metabolic disease.
J Psychopharmacol. 2007 Jun;21(4):355-6. doi: 10.1177/0269881107080215.
6
Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia.
BMC Psychiatry. 2005 Jan 13;5:3. doi: 10.1186/1471-244X-5-3.
7
A Systematized Review of Atypical Antipsychotics in Pregnant Women: Balancing Between Risks of Untreated Illness and Risks of Drug-Related Adverse Effects.
J Clin Psychiatry. 2017 May;78(5):e477-e489. doi: 10.4088/JCP.15r10483.
8
Putting metabolic side effects into perspective: risks versus benefits of atypical antipsychotics.
J Clin Psychiatry. 2001;62 Suppl 27:35-9; discussion 40-1.
9
Which comes first: atypical antipsychotic treatment or cardiometabolic risk?
Acta Psychiatr Scand. 2009 Mar;119(3):171-9. doi: 10.1111/j.1600-0447.2008.01334.x.
10
[Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
Encephale. 2009 Sep;35(4):330-9. doi: 10.1016/j.encep.2008.10.014. Epub 2009 Jul 9.
引用本文的文献
1
Hyperhomocysteinemia in chronic schizophrenia: prevalence, clinical correlates, and paradoxical associations with symptom severity.
Eur Arch Psychiatry Clin Neurosci. 2025 Sep 9. doi: 10.1007/s00406-025-02106-9.
2
Sex differences in schizophrenia: symptomatology, treatment efficacy and adverse effects.
Front Psychiatry. 2025 Jun 16;16:1594334. doi: 10.3389/fpsyt.2025.1594334. eCollection 2025.
3
Schizophrenia and type 2 diabetes risk: a systematic review and meta-analysis.
Front Endocrinol (Lausanne). 2024 Sep 11;15:1395771. doi: 10.3389/fendo.2024.1395771. eCollection 2024.
4
Women with Schizophrenia: Beyond Psychosis.
Community Ment Health J. 2025 Jan;61(1):22-28. doi: 10.1007/s10597-024-01321-3. Epub 2024 Aug 1.
5
Orlistat for the treatment of antipsychotic-induced weight gain: an eight-week multicenter, randomized, placebo-controlled, double-blind trial.
Lipids Health Dis. 2024 Jul 24;23(1):225. doi: 10.1186/s12944-024-02214-w.
6
Combination of UGT1A1 polymorphism and baseline plasma bilirubin levels in predicting the risk of antipsychotic-induced dyslipidemia in schizophrenia patients.
Schizophrenia (Heidelb). 2024 May 17;10(1):52. doi: 10.1038/s41537-024-00473-1.
7
First generation antipsychotic-associated serious adverse events in women: a retrospective analysis of a pharmacovigilance database.
Int J Clin Pharm. 2024 Apr;46(2):515-521. doi: 10.1007/s11096-023-01693-8. Epub 2024 Feb 5.
8
Sex differences in autonomic adverse effects related to antipsychotic treatment and associated hormone profiles.
Schizophrenia (Heidelb). 2024 Jan 6;10(1):6. doi: 10.1038/s41537-023-00430-4.
9
Evidence-Based Recommendations for the Pharmacological Treatment of Women with Schizophrenia Spectrum Disorders.
Curr Psychiatry Rep. 2023 Nov;25(11):723-733. doi: 10.1007/s11920-023-01460-6. Epub 2023 Oct 21.
10
Clinical Laboratory Data in Japan: A Comparative Study of Patients with Psychiatric Disorders and the General Population.
Neuropsychiatr Dis Treat. 2023 Oct 2;19:2061-2068. doi: 10.2147/NDT.S425541. eCollection 2023.
本文引用的文献
1
Adverse events in children and adolescents treated with antipsychotic medications.
Hum Psychopharmacol. 2008 Jun;23(4):283-90. doi: 10.1002/hup.932.
2
An increased risk of stroke among young schizophrenia patients.
Schizophr Res. 2008 Apr;101(1-3):234-41. doi: 10.1016/j.schres.2007.12.485. Epub 2008 Feb 8.
3
Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
Neuro Endocrinol Lett. 2007 Dec;28(6):807-10.
4
Risk of malignancy in patients with schizophrenia or bipolar disorder: nested case-control study.
Arch Gen Psychiatry. 2007 Dec;64(12):1368-76. doi: 10.1001/archpsyc.64.12.1368.
5
Overweight/obesity and cancer genesis: more than a biological link.
Biomed Pharmacother. 2007 Dec;61(10):665-78. doi: 10.1016/j.biopha.2007.10.008. Epub 2007 Nov 1.
6
Association between antipsychotic drugs, antidepressant drugs and venous thromboembolism: results from the EDITH case-control study.
Fundam Clin Pharmacol. 2007 Dec;21(6):643-50. doi: 10.1111/j.1472-8206.2007.00515.x.
7
Clinical implications of antipsychotic-induced hyperprolactinemia in patients with schizophrenia spectrum or bipolar spectrum disorders: recent developments and current perspectives.
J Clin Psychopharmacol. 2007 Dec;27(6):639-61. doi: 10.1097/jcp.0b013e31815ac4e5.
8
Sex differences in myocardial infarction events between patients with and without conventional risk factors: the Modares Heart Study.
Am Heart Hosp J. 2007 Fall;5(4):228-35. doi: 10.1111/j.1541-9215.2007.07301.x.
9
Age and gender effects on olanzapine and risperidone plasma concentrations in children and adolescents.
J Child Adolesc Psychopharmacol. 2007 Oct;17(5):665-74. doi: 10.1089/cap.2006.0045.
10
Comparison of metabolic syndrome incidence among schizophrenia patients treated with aripiprazole versus olanzapine or placebo.
J Clin Psychiatry. 2007 Oct;68(10):1510-6. doi: 10.4088/jcp.v68n1006.
Zotero 插件